How do drug developers select the right CDMO to advance their molecules to market? A global CDMO shares advice on how to form the strongest outsourcing partnerships.
In this co-sponsored webinar brought to you by Samsung Biologics and Pharma's Almanac, Daniel Buckley of Samsung Biologics presents on current dynamics in the CDMO market and key attributes that differentiate the strongest outsourcing partnerships. Watch the full webinar to gain valuable industry insights.
In this webinar, you will learn:
- The critical challenges developers face that CDMOs help overcome
- How to evaluate the capabilities of potential providers to determine right fit
- Samsung Biologics' capabilities and unique platforms
- Future trends on the horizon in the contract development space
Want more key insights about forming the right outsourcing partnerships? Continue reading Daniel Buckley's Q&A article on Pharma's Almanac: Why Choosing the Right CDMO Partner is Essential in Today’s Pharmaceutical Market
Since the airing of this webinar in May 2023, Daniel Buckley is now Associate Director of CDMO Downstream Development at Samsung Biologics.
